Michael Postow was named chief of the Melanoma Service in the Division of Solid Tumor Oncology, and Valeria Silva Merea was named director of the Speech and Hearing Center at Memorial Hospital and the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center.
Kunle Odunsi, deputy director of Roswell Park Comprehensive Cancer Center, was named an at-large director of the Society for Immunotherapy of Cancer Board of Directors.
Glenn D. Steele Jr. was elected board chair of City of Hope, effective June 1.
David Cortez was named associate director for Basic Science Research at Vanderbilt-Ingram Cancer Center.
Jessica Karen Wong will join Fox Chase Cancer Center July 1 as assistant professor in the academic clinical track in the Department of Radiation Oncology.
A new center at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute gives patients direct, expedited access to diagnostic testing for cancer.
Oscar Colegio, the Lawrence P. & Joan Castellani Family Endowed Chair in Dermatology at Roswell Park Comprehensive Cancer Center, died unexpectedly last weekend at a family residence in Connecticut. He was 47.
FDA joins Reagan-Udall, Friends of Cancer Research to form COVID-19 Diagnostics Evidence Accelerator
FDA is participating in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project to advance the development of diagnostics. The accelerator is organized by the Reagan-Udall Foundation for FDA in collaboration with Friends of Cancer Research.
In a letter to House and Senate leaders, Research!America has asked for a massive boost in federal spending to address the damage the U.S. research organizations have sustained as a result of the COVID-19 pandemic.
Researchers in the U.K, Germany and the United States have developed an algorithm to better select breast cancer patients in need of urgent surgery or chemotherapy during the COVID-19 pandemic.
